Factors affecting retroviral vector function and structural integrity - PubMed (original) (raw)
Factors affecting retroviral vector function and structural integrity
J R McLachlin et al. Virology. 1993 Jul.
Abstract
Recombinant retroviruses are widely used for gene transfer into eukaryotic cells and exhibit significant potential for human gene therapy. Despite the utility of retroviral vectors, their design is still essentially empirical. We have constructed a series of reciprocal, double-gene vectors to compare the dual expression of beta-galactosidase (beta-gal) and neomycin phosphotransferase (neor) in a retroviral delivery system. The first gene of the pair was driven by the viral LTR promoter and the internal gene was regulated by either the SV40 virus early promoter or the cytomegalovirus (CMV) major late promoter. Clones of vector producer cells were isolated either by G418 selection for expression of neor, or by fluorescence-activated cell sorting for expression of beta-gal, and the activity of both genes was evaluated. In general, vectors using the SV40 promoter performed better than those with the CMV promoter, regardless of whether the selected gene was regulated by the LTR or the internal promoter. Southern analysis of clones indicated that loss of beta-gal gene function was related to significant rearrangements and deletions in vector structure. We also found that the arrangement of genes within the vector was important. When beta-gal preceded neor, gene expression and vector stability were markedly enhanced relative to vectors containing these genes in the inverse order.
Similar articles
- Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
Byun J, Kim SH, Kim JM, Yu SS, Robbins PD, Yim J, Kim S. Byun J, et al. Gene Ther. 1996 Sep;3(9):780-8. Gene Ther. 1996. PMID: 8875226 - Expression of human bone morphogenic protein 7 in primary rabbit periosteal cells: potential utility in gene therapy for osteochondral repair.
Mason JM, Grande DA, Barcia M, Grant R, Pergolizzi RG, Breitbart AS. Mason JM, et al. Gene Ther. 1998 Aug;5(8):1098-104. doi: 10.1038/sj.gt.3300703. Gene Ther. 1998. PMID: 10326033 - SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
Jayan GC, Cordelier P, Patel C, BouHamdan M, Johnson RP, Lisziewicz J, Pomerantz RJ, Strayer DS. Jayan GC, et al. Gene Ther. 2001 Jul;8(13):1033-42. doi: 10.1038/sj.gt.3301481. Gene Ther. 2001. PMID: 11438838 - Design of retroviral vectors and helper cells for gene therapy.
Hu WS, Pathak VK. Hu WS, et al. Pharmacol Rev. 2000 Dec;52(4):493-511. Pharmacol Rev. 2000. PMID: 11121508 Review. - Retroviral vectors.
Anton G. Anton G. Rev Roum Virol. 1994 Jul-Dec;45(3-4):193-202. Rev Roum Virol. 1994. PMID: 7619740 Review.
Cited by
- Hepatocyte Transplantation: Quo Vadis?
Barahman M, Asp P, Roy-Chowdhury N, Kinkhabwala M, Roy-Chowdhury J, Kabarriti R, Guha C. Barahman M, et al. Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):922-934. doi: 10.1016/j.ijrobp.2018.11.016. Epub 2018 Nov 29. Int J Radiat Oncol Biol Phys. 2019. PMID: 30503786 Free PMC article. Review. - Regulation of cell proliferation and cell density by the inorganic phosphate transporter PiT1.
Byskov K, Jensen N, Kongsfelt IB, Wielsøe M, Pedersen LE, Haldrup C, Pedersen L. Byskov K, et al. Cell Div. 2012 Mar 6;7(1):7. doi: 10.1186/1747-1028-7-7. Cell Div. 2012. PMID: 22394506 Free PMC article. - Early and rapid engraftment of bone marrow-derived microglia in scrapie.
Priller J, Prinz M, Heikenwalder M, Zeller N, Schwarz P, Heppner FL, Aguzzi A. Priller J, et al. J Neurosci. 2006 Nov 8;26(45):11753-62. doi: 10.1523/JNEUROSCI.2275-06.2006. J Neurosci. 2006. PMID: 17093096 Free PMC article. - Caveola-dependent endocytic entry of amphotropic murine leukemia virus.
Beer C, Andersen DS, Rojek A, Pedersen L. Beer C, et al. J Virol. 2005 Aug;79(16):10776-87. doi: 10.1128/JVI.79.16.10776-10787.2005. J Virol. 2005. PMID: 16051869 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources